Dx dialogues: disease-modifying therapies for Alzheimer's and the hope for a cure

Monica Parker, MD, discusses anti-amyloid therapies for Alzheimer's disease, and how subsequent combinations could lead to a cure.

The FDA approved the drug lecanemab in 2023. Learn where treatment stands for this progressive disease.

An overview of TTR stabilizers and gene-silencing therapies for treating hereditary transthyretin (hATTR) amyloidosis.

Find out why cynical people may be more likely to develop dementia.

Strategies for keeping medications and dosing schedules organized when treating congenital adrenal hyperplasia.

Find out about medications and lifestyle habits that can help lower your cholesterol for a healthier heart.